- Home
- BJDX vs ACON Comparison
BJDX vs ACON Comparison
Compare BJDX & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BJDX
- ACON
- Stock Information
- Founded
- BJDX 2015
- ACON 2008
- Country
- BJDX United States
- ACON United States
- Employees
- BJDX N/A
- ACON N/A
- Industry
- BJDX Medical Specialities
- ACON Retail: Computer Software & Peripheral Equipment
- Sector
- BJDX Health Care
- ACON Technology
- Exchange
- BJDX Nasdaq
- ACON Nasdaq
- Market Cap
- BJDX 1.8M
- ACON 1.7M
- IPO Year
- BJDX 2021
- ACON 2022
- Fundamental
- Price
- BJDX $4.05
- ACON $0.11
- Analyst Decision
- BJDX
- ACON Buy
- Analyst Count
- BJDX 0
- ACON 2
- Target Price
- BJDX N/A
- ACON $1.30
- AVG Volume (30 Days)
- BJDX 959.8K
- ACON 991.9K
- Earning Date
- BJDX 11-07-2024
- ACON 11-14-2024
- Dividend Yield
- BJDX N/A
- ACON N/A
- EPS Growth
- BJDX N/A
- ACON N/A
- EPS
- BJDX N/A
- ACON N/A
- Revenue
- BJDX N/A
- ACON $49,289.00
- Revenue This Year
- BJDX N/A
- ACON N/A
- Revenue Next Year
- BJDX N/A
- ACON $186.36
- P/E Ratio
- BJDX N/A
- ACON N/A
- Revenue Growth
- BJDX N/A
- ACON N/A
- 52 Week Low
- BJDX $3.03
- ACON $0.10
- 52 Week High
- BJDX $1,272.00
- ACON $7.39
- Technical
- Relative Strength Index (RSI)
- BJDX 48.88
- ACON 30.75
- Support Level
- BJDX $4.30
- ACON $0.16
- Resistance Level
- BJDX $5.49
- ACON $0.20
- Average True Range (ATR)
- BJDX 0.67
- ACON 0.02
- MACD
- BJDX 0.11
- ACON -0.01
- Stochastic Oscillator
- BJDX 25.52
- ACON 13.37
About BJDX Bluejay Diagnostics Inc.
Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.